• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对屋尘螨(粉尘螨)过敏的哮喘儿童通过减敏疗法抑制迟发性哮喘反应。

Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).

作者信息

Van Bever H P, Stevens W J

机构信息

Department of Paediatrics, University of Antwerp, Belgium.

出版信息

Clin Exp Allergy. 1989 Jul;19(4):399-404. doi: 10.1111/j.1365-2222.1989.tb02405.x.

DOI:10.1111/j.1365-2222.1989.tb02405.x
PMID:2758353
Abstract

In this study, we wanted to test the hypothesis that hyposensitization (HS) abrogates the late asthmatic reaction (LAR). We therefore selected 15 asthmatic children (subjects) sensitized to house dust mite (HDM), as proven by positive prick tests and/or specific IgE via the RAST. All children demonstrated a positive bronchial provocation test (BPT) to HDM; 14 showed a dual asthmatic reaction and one child showed an isolated LAR. All children were treated with anti-asthmatic drugs and received HS. They were rechallenged after 1 yr of HS while their anti-asthmatic medication was not changed, except for beta-agonists which were used only for relief of symptoms. Two BPTs, with a mean interval of 6.4 months, were also performed in eight asthmatic children (controls), who did not receive HS. In the controls, the same reaction pattern was observed during both BPTs. In the subjects, the LAR completely resolved in 5/15 after 1 yr of HS (P = 0.04). Furthermore, as a group, the subjects showed a less severe LAR after 1 yr of HS (expressed as mean fall of FEV1) (P less than 0.0001). The PD20 of the immediate asthmatic reaction (IAR) was the same as before HS was started, but the IAR was also less severe after 1 yr of HS (expressed as mean fall of FEV1) (P = 0.028). From these observations it is concluded that, in asthmatic children, HS may resolve and/or reduce the severity of the LAR. Although the PD20 of the IAR is not changed, the severity of the IAR is also reduced after 1 yr of HS.

摘要

在本研究中,我们想要检验低敏治疗(HS)可消除哮喘迟发反应(LAR)这一假设。因此,我们选择了15名对屋尘螨(HDM)过敏的哮喘儿童(研究对象),其皮内试验阳性和/或通过放射性变应原吸附试验检测到特异性IgE可证实这一点。所有儿童对HDM支气管激发试验(BPT)均呈阳性;14名儿童表现出双重哮喘反应,1名儿童表现出孤立的迟发反应。所有儿童均接受抗哮喘药物治疗并进行低敏治疗。在低敏治疗1年后,他们在抗哮喘药物不变的情况下再次接受激发试验,β受体激动剂仅用于缓解症状时除外。8名未接受低敏治疗的哮喘儿童(对照组)也进行了两次BPT,平均间隔6.4个月。在对照组中,两次BPT期间观察到相同的反应模式。在研究对象中,低敏治疗1年后,15名中有5名迟发反应完全消失(P = 0.04)。此外,作为一个整体,研究对象在低敏治疗1年后迟发反应较轻(以第一秒用力呼气容积(FEV1)平均下降表示)(P<0.0001)。速发哮喘反应(IAR)的PD20与开始低敏治疗前相同,但低敏治疗1年后IAR也较轻(以FEV1平均下降表示)(P = 0.028)。从这些观察结果得出结论,在哮喘儿童中,低敏治疗可能消除和/或降低迟发反应的严重程度。虽然IAR的PD20没有改变,但低敏治疗1年后IAR的严重程度也有所降低。

相似文献

1
Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus).对屋尘螨(粉尘螨)过敏的哮喘儿童通过减敏疗法抑制迟发性哮喘反应。
Clin Exp Allergy. 1989 Jul;19(4):399-404. doi: 10.1111/j.1365-2222.1989.tb02405.x.
2
Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen.对屋尘螨(粉尘螨)或草花粉过敏的哮喘儿童通过脱敏治疗对迟发性哮喘反应的改善。
Allergy. 1988 Jul;43(5):378-85. doi: 10.1111/j.1398-9995.1988.tb00432.x.
3
Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus).低敏疗法对屋尘螨(粉尘螨)过敏患者速发型和迟发型哮喘反应以及组胺反应性的影响。
Eur Respir J. 1992 Mar;5(3):318-22.
4
Lymphocyte transformation test with house dust mite (Dermatophagoides pteronyssinus) in normal children, asthmatic children and asthmatic children receiving hyposensitization.正常儿童、哮喘儿童及接受减敏治疗的哮喘儿童对屋尘螨(粉尘螨)的淋巴细胞转化试验
Clin Exp Allergy. 1993 Aug;23(8):661-8. doi: 10.1111/j.1365-2222.1993.tb01792.x.
5
Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children.尘螨支气管激发试验对哮喘儿童血液嗜酸性粒细胞、嗜酸性粒细胞阳离子蛋白、可溶性白细胞介素-2受体及白细胞介素-6的影响。
Allergy. 1993 Aug;48(6):443-9. doi: 10.1111/j.1398-9995.1993.tb00742.x.
6
Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy.免疫治疗期间及停止免疫治疗后迟发性哮喘反应的演变
J Allergy Clin Immunol. 1990 Aug;86(2):141-6. doi: 10.1016/s0091-6749(05)80058-2.
7
[Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].[常年性支气管哮喘患儿对屋尘螨或粉尘螨致敏的频率]
Monatsschr Kinderheilkd. 1985 Apr;133(4):214-8.
8
The effect of inhaled fenoterol, administered during the late asthmatic reaction to house dust mite (Dermatophagoides pteronyssinus).在对屋尘螨(粉尘螨)的迟发性哮喘反应期间吸入非诺特罗的效果。
J Allergy Clin Immunol. 1990 Apr;85(4):700-3. doi: 10.1016/0091-6749(90)90186-8.
9
[The role of bronchial responsiveness to leukotrienes in antigen-induced immediate and late asthmatic response].
Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Sep;30(9):1687-94.
10
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.普仑司特对特应性和阿司匹林不耐受性哮喘患者激发试验诱导痰中化学介质的影响。
Chest. 2002 Jan;121(1):143-50. doi: 10.1378/chest.121.1.143.

引用本文的文献

1
Impact of allergen immunotherapy in allergic asthma.变应原免疫疗法对过敏性哮喘的影响。
Immunotherapy. 2018 Jun;10(7):579-593. doi: 10.2217/imt-2017-0138. Epub 2018 Mar 23.
2
Can Serum-Specific IgE/Total IgE Ratio Predict Clinical Response to Allergen-Specific Immunotherapy in Children Monosensitized to House Dust Mite?血清特异性IgE/总IgE比值能否预测对屋尘螨单敏儿童的变应原特异性免疫治疗的临床反应?
J Allergy (Cairo). 2012;2012:694094. doi: 10.1155/2012/694094. Epub 2012 Mar 27.
3
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
草花粉免疫疗法对变应原诱导的迟发性皮肤反应中细胞浸润和细胞因子mRNA表达的影响。
J Clin Invest. 1993 Aug;92(2):644-51. doi: 10.1172/JCI116633.
4
New insights into the mechanisms of immunotherapy.免疫疗法机制的新见解。
Eur Arch Otorhinolaryngol. 1995;252 Suppl 1:S64-7. doi: 10.1007/BF02484438.
5
Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.变应原免疫疗法使用指南。加拿大过敏与临床免疫学会。
CMAJ. 1995 May 1;152(9):1413-9.
6
Pharmacotherapy of childhood asthma. An inflammatory disease.
Drugs. 1992 Jul;44(1):36-46. doi: 10.2165/00003495-199244010-00003.